Peripartum cardiomyopathy: a case of patient with triplet pregnancy

Peripartum cardiomyopathy (PPCM) is a rare but potentially devastating complication of pregnancy associated with heart failure due to left ventricular systolic dysfunction occurring within the last month of pregnancy and five month postpartum with no obvious other cause of heart failure and no pre-e...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental obstetrics & gynecology 2016-01, Vol.43 (2), p.274-275
Main Authors: Kotlica, B Kastratović, Cetković, A, Plesinac, S, Macut, D, Asanin, M
Format: Article
Language:English
Subjects:
Adult
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Anti-Arrhythmia Agents - therapeutic use
Anti-Bacterial Agents - therapeutic use
Anticoagulants - therapeutic use
Bromocriptine - therapeutic use
Cardiomyopathy, Dilated - therapy
Cesarean Section
Diuretics - therapeutic use
Female
Heart Failure - therapy
Heparin - therapeutic use
Hormone Antagonists - therapeutic use
Humans
Peripartum Period
Pregnancy
Pregnancy, Triplet
Puerperal Disorders - therapy
Respiration, Artificial
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Peripartum cardiomyopathy (PPCM) is a rare but potentially devastating complication of pregnancy associated with heart failure due to left ventricular systolic dysfunction occurring within the last month of pregnancy and five month postpartum with no obvious other cause of heart failure and no pre-existing heart disease. In the present case report the authors present a woman who developed PPCM on the day after she delivered by cesarean section in 35th weeks of gestation of triplet pregnancy conceived after ovarian stimulation and insemination. A treatment with diuretics, ACE inhibitors, antiarrhythmics, low weight heparin, antibiotics and bromocriptine was applied and resulted in complete recovery. In conclusion, timely detection and initiation of treatment are important factors for complete recovery of patients with PPCM.
ISSN:0390-6663
DOI:10.12891/ceog2040.2016